Search

Search Results

• Awareness assessment for viral hepatitis among patients in different departments of medical institutions and students.

  A. M. Loboda, N. G. Malysh, O. K. Melekhovets, O. M. Chemych, V. I. Mogylenko, D. V. Osypko

  185-196

  2021-05-29
• Circumstances of infection with HCV in selected Polish provinces

  Lidia Sierpińska

  41-52

  2021-02-13
• Тhe role of the internal use of mineral water in the complex treatment of patients with chronic viral hepatitis C with concomitant non-alcoholic fatty liver disease

  Anna Izha

  226-235

  2020-01-31
• Peculiarities of physical and sexual development of girls with autoimmune hepatitis in puberty period

  E. F. Chaykivska

  259-271

  2020-10-30
• The value of polymorphism + 3725G / C TLR4 gene as a marker of liver fibrosis progression in patients with chronic hepatitis C

  T. I. Bevz, D. F. Kyrychenko, G. A. Martynyuk

  328-336

  2019-10-30
• Opportunities for the use of natural and preformed physical factors in the complex treatment of patients with chronic viral hepatitis C with associated non-alcoholic fatty liver disease

  Аnna Izha

  254-263

  2019-12-28
• Features of clinical course of chronic hepatitis in children with oenological diseases

  I. I. Nezgoda, L. V. Moroz, S. Singh, O. O. Singh

  880-896

  2017-04-25
• Hormonal profile of pubertal age girls with chronic viral hepatitis

  E. F. Chaykivska

  342-350

  2020-04-30
• Relationship of cytokine gene polymorphism and the development of liver fibrosis in patients with chronic hepatitis B&C

  K. Usychenko, Y. Berdnyk

  339-348

  2023-02-24
• Рrospects for the use of “dry” carbon dioxide baths in patients with chronic viral hepatitis c with concomitant non-alcoholic fatty liver disease (literature review and own research)

  Anna Izha

  341-349

  2020-06-30
• Relationshipof clinical course, biochemical and immunological changes in patients with chronic hepatitis B+C

  K. Usychenko

  152-160

  2023-05-31
• Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects

  Mateusz Litwin, Agnieszka Mikosińska, Jakub Parys, Patrycja Kałuziak, Aleksandra Witek, Martyna Kaźmierczak, Stanisław Jesionek, Marta Jajczak, Maciej Mossakowski

  57419

  2025-01-17
• Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine

  T. I. Bevz

  281-290

  2020-02-28
• The role of interleukin-17 gene polymorphism (RS612242 C11139G) in the formation of the cryoglobulinemic syndrome in patients with chronic hepatitis C

  K. V. Kalashnyk, Yu. Yu. Riabokon

  248-258

  2019-11-29
• The use of interferon in medicine

  Waldemar Pluta, Wioleta Dudzińska, Anna Lubkowska

  223-237

  2020-06-27
• Clinical and psychopathological features of the course and outcome of the first psychotic episode.

  Yuri Bazhora, Valentyn Gudz, Valentina Mozgova, Kateryna Usychenko, Nikol Shvets

  279-286

  2023-11-30
• Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases

  E. F. Chaykivska

  330-353

  2020-01-31
• Okoliczności rozpoznania zakażenia HCV wśród osób z przewlekłym wirusowym zapaleniem wątroby typu C = The circumstances of diagnosis of HCV infection among people with chronic hepatitis C

  Marta Estera Kowalska, Paweł Kalinowski, Urszula Jolanta Bojakowska

  21-28

  2016-05-04
• Фармакотерапия хронического гепатита С, ассоциированного с аутоиммунным тиреоидитом = Pharmacotherapy of chronic hepatitis C, associated with autoimmune thireoiditis

  T. V. Tregub

  705-710

  2016-11-30
• Механізми репаративної регенерації тканини печінки у статевонезрілих щурів при хронічному токсичному гепатиті = The mechanisms of reparative regeneration of liver tissue in immature rats at chronic toxic hepatitis

  N. A. Rikalo

  587-598

  2015-09-30
• Дослідження фаз клітинного циклу та плоїдності ядерної ДНК клітин печінки статевонезрілих щурів при хронічному токсичному гепатиті та корекції лізиноприлом = Research of cell cycle phases and nuclear DNA ploidy in immature liver cells of rats with chronic toxic hepatitis and lisinopril correction

  N. A. Rikalo, Y. M. Beregovenko

  219-228

  2016-01-30
• Poddawanie się badaniom profilaktycznym przez osoby z przewlekłym wirusowym zapaleniem wątroby typu C = Submission to preventive examinations by people with chronic hepatitis C

  Marta Estera Kowalska, Paweł Kalinowski, Urszula Jolanta Bojakowska

  147-153

  2016-07-09
• Assessment of coping with illness among patients with hepatitis C – on example of research in Poland

  Lidia Sierpińska

  69-86

  2023-04-23
• Disorders peculiarities of the bile-formed and bile-excreting liver functions in the early period of traumatic disease on the background of chronic hepatitis

  R. Blyzniuk, T. Dzetsiukh

  61-68

  2015-10-13
• Vitamine D supply in girls of puberty age with autoimmune hepatitis

  E. F. Сhaykivska, V. S. Berezenko, T. F. Tatarchuk

  366-379

  2020-05-29
• Dependence of changes in hematological and integrative parameters in patients with chronic viral hepatitis C on the received antiviral therapy

  A. H. Lishnevska, M. D. Chemych

  177-195

  2020-02-28
• The treatment dynamics assessment among patients with chronic viral hepatitis B, infected with human immunodeficiency virus

  L. V. Moroz, T. O. Melnyk

  393-409

  2020-10-30
• Aktywność fizyczna osób z przewlekłym wirusowym zapaleniem wątroby typu C

  Marta Estera Kowalska, Paweł Kalinowski, Urszula Bojakowska

  275-282

  2016-02-27
• The peculiarities of medical care organizing forpatients with viral hepatitis in Ukraine

  Vasyl Mykolayovych Mykhalchuk, Valeriy Anatoliyovych Pishchikov

  279-288

  2020-01-31
• Laboratory-biochemical features of the course of chronic hepatitis C with polymorphism rs11536889 + 3725G/C of TLR-4 gene

  T. I. Bevz, G. A. Martynyuk, L. A. Livshits, Y. M. Demchyshyn

  254-261

  2020-04-30
• Prevention of hepatitis B

  Marta Estera Kowalska, Paweł Kalinowski, Urszula Jolanta Bojakowska

  315-321

  2017-07-18
• Level of health behaviours of HCV infected patients treated with dialysotherapy

  Lidia Sierpińska, Karolina Lis

  148-159

  2019-12-31
• Comparison of diagnostic informative value of the methods for the determination of direct (hyaluronic acid) and indirect (alanine aminotransferase, aspartate aminotransferase, de Rithis coefficient) of liver fibrosis markers in patients with chronic viral hepatitis C

  L. V. Moroz, I. Yu. Bondaruk

  676-688

  2019-05-27
• Comparison of the diagnostic efficiency of various noninvasive methods for diagnosing liver fibrosis in patients with chronic viral hepatitis C

  L. V. Moroz, I. Yu. Bondaruk, A. A. Popovich, S. N. Kulias

  546-555

  2019-06-28
• The dynamics of cytolytic syndrome parameters in the period of late manifestations of cranioskeletal trauma in case of concomitant chronic hepatitits and the effectiveness of armadine correction

  O. Prokhorenko

  392-401

  2021-11-30
• DAA - directly acting antivirals - as a new, more efficient solution of the chronic hepatitis C treatment and theirs various application.

  Kamila Abram, Patryk Banaś, Justyna Adamus, Jakub Rafał Pierzchała, Katarzyna Bednarz, Natalia Sobańska, Aleksandra Paulina Banasiak, Rafał Teichman, Jakub Kasprowicz, Michał Hyjek

  200-206

  2023-02-02
• Instruments for measurement of the quality of life of patients infected with HCV virus

  Lidia Sierpińska

  185-196

  2017-05-13
• Hepatocellular carcinoma in patients with chronic hepatitis C – case study

  Lidia Sierpińska, Sebastian Jaworski

  229-237

  2022-03-29
• Influence of complex treatment with quercetin inclusion on cytokine profile indicators in chronic nonviral hepatitis patients

  V. P. Prysyazhnyuk

  177-185

  2017-10-30
• New diagnostic markers for the degree of liver fibrosis in children with chronic viral hepatitis

  I. I. Nezgoda, L. V. Moroz, S. Singh, O. O. Singh

  1040-1055

  2017-06-30
• Renal dysfunction in patients with chronic toxic hepatitis and ways of its correction

  O. Kvasnytska, A. Gozhenko

  183-189

  2023-05-31
• Ultrasonographic characteristics of morphometric and hemodynamic parameters of the liver and spleen in pediatric patients with chronic viral hepatitis B and C

  Y. Demchyshyn, I. Nezgoda, S. Poprotska, A. Asaulenko

  201-206

  2021-11-30
• Morphological changes in kidney glomeruli of rats with chronic toxic hepatitis and its correction with lisinopril, L-arginine-L-glutamate and their combination

  N. A. Rykalo, Yu. M. Berehovenko, O. V. Androshchuk

  632-639

  2019-05-27
• Non-alcoholic fatty liver disease after liver transplantation: A lifestyle reloaded

  Lubomir Skladany, Jana Badinkova, Svetlana Adamcova-Selcanova

  116-133

  2017-10-10
• Liver morphological changes and proinflammatory cytokines in experimental animals in case of cirrhosis

  O. I. Romak, Yu. Sadovska, I. Goryuk

  690-699

  2017-03-29